Safety and efficacy of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with bicuspid aortic stenosis: A Systematic review and meta-analysis

Ahmed Farid Gadelmawla, Ahmed Mansour, Ahmed Elbataa, Osama Hamdi Asiri, Amnah Ali Alharbi, Fatimah Ashraf Alquraish, Fatem Saleh Al-Ibrahim, Abdulaziz Fahad AlHasani, Turki Nashi Alharbi, Ruba Mohammed AL Murayyi, Abdulelah Ghazi Alotaibi, Hamza A. Abdul-Hafez, Ihab Suliman, Faculty of Medicine, Menoufia University, Faculty of Medicine, Al-Azhar University, College of Medicine, King Khalid University, Saudi Arabia, College of Medicine and Surgery, Taibah University, Saudi Arabia, College of Medicine, Imam Abdulrahman Bin Faisal University, Saudi Arabia, College of Medicine, Umm Al-Qura University, Saudi Arabia, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia, Department of Medicine, King Abdulaziz Medical City, Saudi Arabia, Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, King Abdulaziz Medical City, King Abdulaziz Cardiac Center, Ministry of National Guard Health Affairs

Perfusion

Published online on June 24, 2026

Abstract

Perfusion, Ahead of Print.
BackgroundBicuspid aortic valve (BAV) disease is a leading cause of aortic stenosis (AS). Surgical aortic valve replacement (SAVR) has traditionally been regarded as the best therapeutic option for bicuspid AS. However, the distinctive anatomical ...